Evolent Health, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Evolent Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-12-31 was $0.00.
- Evolent Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $23.07M, a 77.38% decline year-over-year.
- Evolent Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-12-31 was -$142.00K.
- Evolent Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was $102.00M.
- Evolent Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $23.07M, a 77.35% decline from fiscal 2022.
- Evolent Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $101.86M, a 257.49% increase from fiscal 2021.
- Evolent Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $28.49M.
- Evolent Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $23.07M 10-K · filed 2026-02-25 |
| 2023-09-30 | $23.07M 10-Q · filed 2024-11-08 | |
| 2022-12-31 | -$142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $101.86M 10-K · filed 2025-02-21 |
| 2022-09-30 | $102.00M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $28.49M 10-K · filed 2023-02-24 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 | |
| 2015-12-31 | $78.55M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $39.27M 10-K · filed 2018-03-01 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |